Our clinically proven concentric
magnets
are helping athletes to
play harder & recover faster

Our clinically proven concentric
magnets
are helping athletes to
play harder & recover faster

Investing in Active Lifestyles & Healthy Living

Relevium is a publicly traded corporation strategically focused in musculoskeletal and mental functional well-being specifically in the areas of pain relief, recovery and performance enhancement.

Our Focus

pain relief

Pain avoidance is one of the most important drivers of consumer behavior worldwide. The market for pain relief is estimated to be about $39 billion and is expected to reach $41.5 billion in 2017 with a compound annual growth of over 5%. The primary focus of Relevium in this vertical segment is on wearable devices that reduce musculoskeletal pain caused by injuries or mechanical dysfunction.

recovery

Musculoskeletal injuries such as sprains and strains are among the most common and costly burdens to the medical system and workforce. Direct costs (medical expenses) related to injuries are estimated at $190 billion per year and indirect costs (loss in wages) $120 billion per year. The Integrated Benefits Institute suggest that for every 100 employees the costs to companies’ amounts to $103,000 per year. The primary focus of Relevium in this vertical segment is on wearable technologies that reduce recovery times in treating musculoskeletal injuries.

performance

Traditionally, under the global sports apparel market and encompassing over $135 billion of business in 2012, Performance has widened in scope to include Nutrition and Mind. Driven by a growing fitness consciousness, living better and longer, the need for performance enhancement is expected to drive market growth exponentially. The primary focus of Relevium in this vertical segment is on Nutraceuticals and Wearables that enhance overall performance and reduce recovery time.

Relevium Technologies Inc. Press Releases

Relevium Announces Private Placement and Provides Update on BioGanix Aquisition

Relevium Technologies Inc., a consolidator of e-commerce assets in Health and Wellness, is pleased to provide the following update to its press release of December 22, 2016 announcing a binding letter of intent (the “LOI”) to acquire the assets of BioGanix Limited (“BGL”), a privately-held nutraceutical company in Houston, Texas focused on heart, brain, digestive health and joint support products sold through primarily through e-commerce platforms.

read more

Relevium Provides Update on BioGanix and Trading Halt

Relevium Technologies Inc. a consolidator of e-commerce assets in Health and Wellness, announced on December 22, 2016 that it had executed a binding letter of intent (the “LOI”) to acquire the assets of BioGanix Limited (“BGL”), a privately- held nutraceutical company based in Houston, Texas and focused on heart, brain, digestive health and joint support products sold through primarily through e-commerce platforms.

read more

Our Team

Subscribe To Our Newsletter

You have Successfully Subscribed!